Side-by-side comparison of AI visibility scores, market position, and capabilities
Molecular diagnostics company developing novel biomarker detection tests for earlier disease identification; proprietary antibody-based assays targeting clinical laboratory deployment.
AOA Dx (formerly known under a different name) is a molecular diagnostics company developing novel diagnostic tests for earlier and more accurate disease detection, focusing on underserved testing gaps in clinical settings. The company applies innovative biomarker detection approaches to improve diagnostic accuracy in categories where current testing misses significant patient populations or delivers delayed results.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.